Patent Assignment
Reel/Frame 066988/0525
Assignment of Assignor's Interest
Recorded: 2024-04-03
Pages: 8
Assignor
CLOUDBREAK THERAPEUTICS, LLC
Executed: 2021-08-31
Assignee
ADS THERAPEUTICS LLC
15615 ALTON PARKWAY, SUITE 450, IRVINE, CALIFORNIA, 92618-3308
Covered Property
(1)
Compositions and Methods of Using Nintedanib for Treating Ocular Diseases with Abnormal Neovascularization
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.